You are here: Industry Insights > Biopharma

News List

Few biopharma buyouts in quiet third quarter evaluate
October 22, 2018
The $6.6bn of M&A deals announced by drug makers in third quarter of 2018 marks the slowest three-month period since 2013.
Changchun High, New Technology form $200 M JV biospectrumasia
September 29, 2018
Changchun will fund the JV with $100 million while Alvotech will contribute $10 million plus six drug licenses valued at $90 million.
Regen BioPharma Reports Molecule Screening Success contractpharma
August 31, 2018
Regen BioPharma Inc. has identified a series of small molecule drugs that inhibit NR2F6. Regen's screening process demonstrated that its recently identified novel chemical compounds appear to inhibit NR2F6 and show potential for treating autoimmune diseas
PhRMA survey shows US biopharma exceeded R&D spending record in 2017 drugs
August 15, 2018
Spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) on research and development (R&D) set a new record by totalling $71.4bn in 2017, according to the 2018 PhRMA survey.
US regulators on track for another strong year of approvals epvantage
July 27, 2018
A nurturing regulatory environment is one of biopharma’s strongest tailwinds, and there are few signs of this petering out.
Prestige BioPharma, Alvogen Enter Agreement contractpharma
July 03, 2018
Prestige BioPharma and Alvogen have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar (HD201; Hervelous™) in Central and Eastern Europe.
The top 5 highest-paid women biopharma executives in 2017 fiercepharma
June 29, 2018
Women and men almost equally shared all positions in the life sciences world, but women are not advancing in their biopharma careers at the same pace as men, according to a recent report by the Massachusetts Biotechnology Council and recruiting firm Lifts
Can-Fite says liver cancer trial is delayed—but it could be good news fiercebiotech
June 25, 2018
Israeli microcap Can-Fite BioPharma won’t get a readout from its midstage trial of liver cancer candidate namodenoson as soon as it hoped, but said the data so far are looking good.
PDL BioPharma Appoints BD VP contractpharma
May 22, 2018
Jill M. Jene, Ph.D. has been appointed vice president, business development, PDL BioPharma, Inc
FDA Commissioner Goes to Bat for the BioPharma Industry biospace
April 19, 2018
During a meeting with FDA Commissioner Scott Gottlieb earlier this week, government and healthcare officials in New Jersey highlighted the need to hasten the approval of new drugs and permanently eliminate the tax on medical devices.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page